tiprankstipranks
Global Cord Blood (CORBF)
OTHER OTC:CORBF
US Market

Global Cord Blood (CORBF) Income Statement

Compare
177 Followers

Global Cord Blood Income Statement

Last quarter (Q4 2021), Global Cord Blood's total revenue was ¥297.38M, a decrease of -5.84% from previous quarter. In Q4, Global Cord Blood's net income was ¥104.78M. See Global Cord Blood’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Mar 21Mar 20Mar 19
Total Revenue
¥ 1.24B¥ 1.12B¥ 1.24B¥ 988.48M
Gross Profit
¥ 1.06B¥ 934.04M¥ 1.03B¥ 785.20M
Operating Expenses
¥ 451.08M¥ 406.54M¥ 465.43M¥ 402.88M
Depreciation and Amortization
¥ 47.92M¥ 49.99M¥ 52.69M¥ 52.46M
EBITDA
¥ 656.79M¥ 3.90B¥ 4.31B¥ 2.92B
Operating Income
¥ 608.87M¥ 527.50M¥ 568.78M¥ 382.32M
Other Income/Expenses
¥ 18.97M¥ 63.78M¥ 20.12M¥ -169.40M
Pretax Income
¥ 627.84M¥ 591.28M¥ 588.90M¥ 357.08M
Net Income
¥ 501.06M¥ 492.04M¥ 478.92M¥ 291.63M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 4.12¥ 4.07¥ 3.97¥ 2.42
Diluted EPS
¥ 4.12¥ 4.07¥ 3.97¥ 2.42
Weighted Average Shares Outstanding
121.55M 121.55M 121.55M 121.27M
Weighted Average Shares Outstanding (Diluted)
121.55M 121.55M 121.55M 121.42M
Currency in CNY

Global Cord Blood Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis